Integra LifeSciences Holdings (IART)
Current ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 1,058,040 | 1,161,500 | 1,153,720 | 1,237,200 | 858,168 |
| Total current liabilities | US$ in thousands | 306,980 | 320,906 | 340,021 | 401,013 | 331,309 |
| Current ratio | 3.45 | 3.62 | 3.39 | 3.09 | 2.59 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $1,058,040K ÷ $306,980K
= 3.45
The current ratio of Integra Lifesciences Holdings Corp has shown a consistent upward trend from 2019 to 2022, indicating a strengthening liquidity position. In 2019, the current ratio was 2.59, which increased to 3.45 by the end of 2023. This demonstrates the company's ability to meet its short-term obligations as its current assets have been increasing relative to its current liabilities over the years. However, the slight decrease in the ratio from 2022 to 2023 could suggest a potential slight reduction in short-term liquidity, although the ratio remains well above 1, indicating a healthy liquidity position overall.
Peer comparison
Dec 31, 2023